Latest Content

Biome Technologies PLC
Bioplastics grows 7% despite global shipping issues

Biome Technologies (Biome) reported continued growth in its key Bioplastics division in the first half but with the rate of revenue growth being limited to 7% by external factors outside of the Group’s control. Similarly, revenues within the Stanelco RF division (Stanelco) declined marginally in H1 being impacted by component delivery delays, particularly in Q2. The Board believesthat the Group’s performance remains in line with current market expectations and consequently our forecasts remain u

 View

  • 29 Jul 21
  • -
  • -
Indices and Markets
AIM MARKET UPDATE Q2 2021

AIM’s strong to start to 2021 as seen in Q1 accelerated into Q2 with £2.8bn raised in the quarter (Q1 £2.0bn). The £1.7bn raised in June was the most in any single month since July 2007.

 View

  • 26 Jul 21
  • -
  • -
Franchise Brands plc
Strong recovery and growth across all divisions

In the half year to June 2021 Franchise Brands posted an increase in revenues of 18% and an increase in adjusted EBITDA of 50% with strong cash conversion of 84%. Revenue and adjusted EBITDA increased across all divisions as COVID-related restrictions were progressively lifted through the period. The easing of restrictions in the hospitality sector and the digital transformation continuing at pace, will further benefit the H2 outcome. The Board is confident regarding the prospects for organic gr

 View

  • 22 Jul 21
  • -
  • -
Panthera Resources Plc
Interesting drilling results at Bassala on the cards

Panthera Resources, the West Africa-focused gold junior, has announced the completion of an inaugural drilling programme at its Bassala project in southern Mali. Drilling results should be available in about a month. Ahead of these, it is important to note that drilling has been undertaken in the highly prospective Baoule-Mossic Domain of the Man-Leo Shield that hosts prolific greenstone formations, the source for all known gold deposits in southern Mali. Bassala is located close to three large-

 View

  • 15 Jul 21
  • -
  • -
Nuformix Plc
Progressing NXP002 towards clinical trials

Nuformix is making good progress on the development of NXP002, its novel inhaled form of tranilast intended for idiopathic pulmonary fibrosis (IPF). It is executing a plan designed to generate a phase 1-ready formulation in c. 18 months’ time, when it may be able to seek a licensing partner. IPF is an attractive market opportunity with around ten projects in mid/late-stage clinical trials, only two of which are delivered by inhalation, a route with self-evident advantages in this indication. The

 View

  • 15 Jul 21
  • -
  • -
ReNeuron Group plc
hRPC study confirmed back on track

Recruitment has resumed in the US into the Phase 2a trial of the lead programme hRPC in retinitis pigmentosa (RP) after an investigation following the presumed bacterial infection that caused its temporary suspension last month. We expect resumption in the UK and Spain by August after regulatory confirmation. The quick resolution of this issue seems to have caused only a modest, one quarter, delay. The three-month data on the higher dose (2m cell) extension arm is due in Q4 2021 and will be impo

 View

  • 08 Jul 21
  • -
  • -
 

Allenby Capital Research and Daily Commentaries

Research Tree offers Allenby Capital research, providing ongoing coverage of 166 shares , as well as macro-economic categories including: Economic Data, Commodities - Energy, Commodities - Metals & Mining, and Indices and Markets. We offer 657 reports from Allenby Capital on Research Tree.

  • Research reports provided by Allenby Capital

  • Companies covered by Allenby Capital

  • Sectors covered by Allenby Capital


Related Content

View the latest research on other companies in the sector. 

Allenby Capital TMT Update 05.08.19 (BBSN.L, MBT.L)

Brave Bison Group plc* (BBSN.L, 1.45p/£8.8m) Interims: Swift response to Facebook content policy changes (31.07.19) | Mobile Tornado Group plc* (MBT.L, 5.2p/£18.1m) Subscription: Additional working capital to fund bundled PTT growth (31.07.19)

Brave Bison Group Plc Mobile Tornado Group Plc

  • 05 Aug 19
  • -
Allenby Capital TMT Update 29.07.19 (TERN.L, GETB.L)

Tern plc* (TERN.L, 12p/£28.4m) Investee company update (25.07.19) | GetBusy plc (GETB.L, 43p/£21.8m) Meeting with management: Revenue visibility & growth opportunity (23.07.19)

Tern PLC GetBusy Plc

  • 29 Jul 19
  • -
Allenby Capital TMT Update 15.07.19 (GFIN.L, MIRA.L, BOOM.L)

Gfinity plc* (GFIN.L, 5.25p/£23.6m) Proposed placing of £5.25m (15.07.19) | Mirada plc* (MIRA.L, 1.0p/£8.9m) Finals - Revenue growth & profitability; positive outlook (12.07.19) | Audioboom plc* (BOOM.L, 255p/£35.7m) New podcast studios in New York increases capacity (12.07.19)

GFIN BOOM MIRA

  • 15 Jul 19
  • -
Allenby Capital TMT Update 08.07.19 (CPX.L, MIRA.L, BIRD.L, BOOM.L)

CAP-XX Ltd* (CPX.L, 4.5p/£14.9m) Court action settlement and licence agreement (02.07.19) | Mirada plc* (MIRA.L, 0.9p/£7.8m) Successful disposal of non-core business (05.07.19) | Blackbird plc* (BIRD.L, 7.375p/£21.8m) Contract win: Global Rapid Rugby highlights (03.07.19) | Audioboom plc* (BOOM.L, 242.5p/£34.0m) Notice of results (04.07.19)

CPX BIRD BOOM MIRA

  • 08 Jul 19
  • -
Allenby Capital TMT Update 01.07.19 (TERN.L, ZOO.L, ACC.L)

Tern plc* (TERN.L, 11.25p/£26.6m) Capital Markets Event: Exposure to global IoT market (24.06.19) | ZOO Digital plc (ZOO.L, 63p/£46.9m) FY19 results: Development and disruption in OTT market (26.06.19) | Access Intelligence plc (ACC.L, 58.0p/£35.4m) Cessation of coverage (01.07.19)

TERN ZOO ACC

  • 01 Jul 19
  • -
Allenby Capital TMT Update 24.06.19 (MWE.L, BIRD.L, ACC.L, BBSN.L, ECSC.L)

MTI Wireless Edge Ltd* (MWE.L, 23.0p/£20.0m) Acquisition: Capturing more of the value chain (24.06.19) | Blackbird plc* (BIRD.L, 7.75p/£22.9m) Contract win: Major US broadcaster secured (19.06.19) | Access Intelligence plc* (ACC.L, 58p/£35.4m) H1 trading update: Major US broadcaster secured (19.06.19) | Brave Bison Group plc* (BBSN.L, 1.65p/£10.0m) AGM statement: Planned diversification (19.06.19) | ECSC Group plc* (ECSC.L, 75p/£16.8m) AGM statement: Managed Services growth increases recurring revnue (19.06.19)

MWE ACC BBSN ECSC

  • 24 Jun 19
  • -